MedTrace Logo

Culturally Tailored Educational Video to Promote Lung Cancer Screening in Vulnerable Communities

NCT06010355 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2026-02-17

No results posted yet for this study

Summary

This clinical trial evaluates the impact of a culturally tailored educational video on the perceptions of lung cancer and lung cancer screening in vulnerable communities. Lung cancer is the most common cancer type. African-American communities have a higher rate than any other racial or ethnic group in the United States and accounts for the highest number of deaths among African-Americans. Lung cancer is in the top three causes of cancer death among Asian men and women. Research has shown that low-income, minority and immigrant individuals may be under resourced to make decisions about prevention programs and early detection measures for lung cancer. A culturally tailored educational video may be an effective method to help people learn about lung cancer, susceptibility toward lung cancer and lung cancer screening. This may increase lung cancer screening in vulnerable communities.

Conditions

  • Cigarette Smoking-Related Carcinoma
  • Lung Carcinoma

Interventions

PROCEDURE

Discussion

Participate in focus groups

OTHER

Media Intervention

Watch culturally appropriate video

OTHER

Interview

Undergo interview

OTHER

Media Intervention

Watch culturally appropriate video

OTHER

Test

Complete test

Sponsors & Collaborators

  • Thomas Jefferson University

    lead OTHER

Principal Investigators

  • Amy R Leader, DrPH, MPH · Thomas Jefferson University

Study Design

Allocation
NON_RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-01
Primary Completion
2025-02-19
Completion
2025-02-19

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06010355 on ClinicalTrials.gov